m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients
BackgroundColon adenocarcinoma (COAD) is the most common subtype of colon cancer. However, the 5-year survival rate of COAD patients remains unsatisfactory. N6-methyladenosine (m6A) and long noncoding RNAs (lncRNAs) play essential roles in the occurrence and development of COAD. Herein, we are commi...
Main Authors: | Chenyang Xu, Tingting He, Xinxin Shao, Ling Gao, Lei Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.920023/full |
Similar Items
-
Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
by: Yimin Sun, et al.
Published: (2023-03-01) -
Identification of novel key regulatory lncRNAs in gastric adenocarcinoma
by: Houri Razavi, et al.
Published: (2022-05-01) -
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
by: Jinxin Tang, et al.
Published: (2023-04-01) -
5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma
by: Yinghui Huang, et al.
Published: (2022-02-01) -
Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)